Iftikhar Kullo
Professor,
Mayo Clinic
Iftikhar Kullo MD
Dr. Iftikhar Kullo is a cardiologist and research scientist in the Department of Cardiovascular Medicine at the Mayo Clinic, Rochester, Minnesota. His research is focused on the genetic basis of atherosclerosis and lipid disorders, as well as implementation of genomic medicine. He heads the Atherosclerosis and Lipid Genomics Laboratory, chairs the Cardiovascular Genomics Task Force, directs the Early Atherosclerosis and Familial Hypercholesterolemia Clinics, and is the Program Director of the Cardiovascular Genomics Fellowship Training Program at Mayo Clinic Rochester, Minnesota. Dr. Kullo's work on genomic discovery and implementation, particularly in the area of polygenic risk assessment, has been widely cited. He has published more than 420 scientific papers and has mentored nearly 100 medical students, residents, fellows, and junior faculty. Dr. Kullo has been funded by the NIH since 2003 and is a Principal Investigator in the eMERGE and PRIMED Networks of the NHGRI. He serves on the US National Advisory Council on Human Genome Research. Dr. Kullo is deeply interested in reducing disparities and inequity in genomic medicine. He is working with underserved communities to implement genomic medicine programs to improve health in these communities.
Dr. Iftikhar Kullo is a cardiologist and research scientist in the Department of Cardiovascular Medicine at the Mayo Clinic, Rochester, Minnesota. His research is focused on the genetic basis of atherosclerosis and lipid disorders, as well as implementation of genomic medicine. He heads the Atherosclerosis and Lipid Genomics Laboratory, chairs the Cardiovascular Genomics Task Force, directs the Early Atherosclerosis and Familial Hypercholesterolemia Clinics, and is the Program Director of the Cardiovascular Genomics Fellowship Training Program at Mayo Clinic Rochester, Minnesota. Dr. Kullo's work on genomic discovery and implementation, particularly in the area of polygenic risk assessment, has been widely cited. He has published more than 420 scientific papers and has mentored nearly 100 medical students, residents, fellows, and junior faculty. Dr. Kullo has been funded by the NIH since 2003 and is a Principal Investigator in the eMERGE and PRIMED Networks of the NHGRI. He serves on the US National Advisory Council on Human Genome Research. Dr. Kullo is deeply interested in reducing disparities and inequity in genomic medicine. He is working with underserved communities to implement genomic medicine programs to improve health in these communities.
Sessions
-
21-Mar-2025